Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$54.9 - $105.21 $1.71 Million - $3.28 Million
-31,158 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$105.0 - $178.37 $3.27 Million - $5.56 Million
31,158 New
31,158 $3.28 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.96B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Partners Group Holding Ag Portfolio

Follow Partners Group Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Partners Group Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Partners Group Holding Ag with notifications on news.